Breaking News

Kaneka Eurogentec Produces 25g of mRNA in One Batch

Demonstrates mRNA production capabilities suitable for late clinical and commercial scales.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kaneka Eurogentec, an FDA inspected contract development and manufacturing organization (CDMO), said that its mRNA manufacturing facility has successfully produced a 25-gram batch of mRNA for a U.S. customer. Eurogentec’s GMP mRNA manufacturing service offers in vitro transcription (IVT), purification, quality control and batch release of GMP material up to 25-gram scale in its current facility in Belgium. In this project Eurogentec successfully produced and purified 25 g of material in one b...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters